BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17693996)

  • 1. Successful biologic treatment of ocular mucous membrane pemphigoid with anti-TNF-alpha.
    John H; Whallett A; Quinlan M
    Eye (Lond); 2007 Nov; 21(11):1434-5. PubMed ID: 17693996
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept.
    Prey S; Robert PY; Drouet M; Sparsa A; Roux C; Bonnetblanc JM; Bédane C
    Acta Derm Venereol; 2007; 87(1):74-5. PubMed ID: 17225020
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
    Canizares MJ; Smith DI; Conners MS; Maverick KJ; Heffernan MP
    Arch Dermatol; 2006 Nov; 142(11):1457-61. PubMed ID: 17116836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of etanercept in anti-laminin 5 (laminin 332) mucous membrane pemphigoid.
    Schulz S; Deuster D; Schmidt E; Bonsmann G; Beissert S
    Int J Dermatol; 2011 Sep; 50(9):1129-31. PubMed ID: 22126878
    [No Abstract]   [Full Text] [Related]  

  • 5. Recalcitrant cicatricial pemphigoid treated with the anti-TNF-alpha agent etanercept.
    Kennedy JS; Devillez RL; Henning JS
    J Drugs Dermatol; 2010 Jan; 9(1):68-70. PubMed ID: 20120429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of delayed pressure urticaria with anti-TNF-alpha.
    Magerl M; Philipp S; Manasterski M; Friedrich M; Maurer M
    J Allergy Clin Immunol; 2007 Mar; 119(3):752-4. PubMed ID: 17336621
    [No Abstract]   [Full Text] [Related]  

  • 7. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
    Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
    Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept).
    Pastor N; Betlloch I; Pascual JC; Blanes M; Bañuls J; Silvestre JF
    Clin Exp Dermatol; 2006 Jan; 31(1):152-3. PubMed ID: 16309525
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of mucous membrane pemphigoid with infliximab.
    Heffernan MP; Bentley DD
    Arch Dermatol; 2006 Oct; 142(10):1268-70. PubMed ID: 17043180
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
    Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
    Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in mucous membrane pemphigoid.
    Daniel E; Thorne JE
    Curr Opin Ophthalmol; 2008 Jul; 19(4):292-7. PubMed ID: 18545009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular cicatricial pemphigoid.
    Vandeveer MR
    J Am Optom Assoc; 1991 Mar; 62(3):166-9. PubMed ID: 1813519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostics and pharmacological treatment of ocular cicatrical pemphigoid].
    Brydak-Godowska J; Moneta-Wielgoś J; Pauk-Domańska M; Dróbecka-Brydak E; Samsel A; Kecik M; Kowalewski C; Mackiewicz W; Kecik D
    Klin Oczna; 2005; 107(10-12):725-7. PubMed ID: 16619831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of infliximab following a failed course of etanercept in a pediatric patient.
    Farnsworth NN; George SJ; Hsu S
    Dermatol Online J; 2005 Dec; 11(3):11. PubMed ID: 16409907
    [No Abstract]   [Full Text] [Related]  

  • 15. Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?
    Salvarani C; Pipitone N; Boiardi L; Hunder GG
    Ann Rheum Dis; 2008 May; 67(5):577-9. PubMed ID: 18408108
    [No Abstract]   [Full Text] [Related]  

  • 16. Ocular cicatricial pemphigoid: all conjunctival scarring is not trachoma.
    Varughese S; Gupta N
    Indian J Ophthalmol; 2003 Dec; 51(4):361. PubMed ID: 14750630
    [No Abstract]   [Full Text] [Related]  

  • 17. Psoriasis exacerbation after a flu-like syndrome during anti-TNF-alpha therapy.
    Cassano N; Coviello C; Loconsole F; Miracapillo A; Vena GA
    Eur J Dermatol; 2006; 16(3):316-7. PubMed ID: 16709508
    [No Abstract]   [Full Text] [Related]  

  • 18. Adolescent plaque psoriasis: our experience using etanercept.
    Ruiz-Villaverde R; Sánchez-Cano D; Abalos-Medina G
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):976-7. PubMed ID: 19207668
    [No Abstract]   [Full Text] [Related]  

  • 19. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
    Spadaro A; Ceccarelli F; Scrivo R; Valesini G
    Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on ocular cicatricial pemphigoid and emerging treatments.
    Queisi MM; Zein M; Lamba N; Meese H; Foster CS
    Surv Ophthalmol; 2016; 61(3):314-7. PubMed ID: 26708362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.